Thank you, Steve Jobs …for enlarging my brother’s world A remarkable post that speaks for itself…
My contention is that the AJP editorial mentioned in my last post [Anxiety Disorders and Antipsychotic Drugs: A Pressing Need for More Research] has an undeclared Conflict of Interest. This isn’t enough to allow the readers to know who is writing this article: Dr. Breier has served on advisory boards or as a consultant for […]
I don’t suppose that this report in the American Journal of Psychiatry comes as any great surprise. It documents the dramatic increase in the use of Atypical Antipsychotics by psychiatrists to treat anxiety over the last decade. But the story of this article is a bit more complicated. I apologize for the length of this […]
It was a picture perfect Georgia Mountain week-end, great for a community Bar-B-Q in the mega-cooker – dinner on the grounds for 100 or so. Hardly a thought of matters medical or psychiatric that day. But the grey days that followed were equally fine days for some review time with the history of the algorithms […]
New Study: Biomarkers are Cool, but Nearly Useless for Predicting Alzheimer’s Carlat Psychiatry Blog by Danny Carlat October 12, 2011 Everybody would like to find a brain scan or a blood or spinal fluid test to predict Alzheimer’s disease. Such objective tests seem inherently more reliable than the clinical interview. Recently we’ve seen various studies […]
Stephany of Soulful Sepulcher points us to this not so surprising development in the world of foundation nomenclature: Big Changes at CABF The Balanced Mind Foundation by Susan Resko October 5, 2011 some members of the cabf bmf scientific advisory council The Child & Adolescent Bipolar Foundation [CABF] launched its pioneering website, www.bpkids.org, in 1999 […]
At HLS, former investigator questions the relationship between physicians and pharmaceutical industry Harvard Law School by Alexander Heffner October 04, 2011 In the first lecture of the Edmond J. Safra Center for Ethics series, Paul Thacker, an investigative journalist and former U.S. Senate Finance Committee staffer, said that big pharmaceutical dollars not only own physicians […]
The public health burden of mental illness is without question, but Tom Insel and friends have turned it into a "brand." It begins Insel’s every speech and is in the introduction to many of the journal articles of a subset of our biological researchers. It’s a particularly hot issue in Australia right now because of […]
This is a rambler, following up on this morning’s question about paper churning. Dr. John Rush is the master at it [whatever the point]. Rush’s CV as of January 2011 lists 638 articles. On PubMed he has 533 as of today. Whatever the actual count, it’s pretty impressive. Back when I was looking at STAR*D, […]
Effects of Race and Ethnicity on Depression Treatment Outcomes: The CO-MED Trial by Ira M. Lesser, M.D., Sidney Zisook, M.D., Bradley N. Gaynes, M.D., M.P.H., Stephen R. Wisniewski, Ph.D., James F. Luther, M.A., Maurizio Fava, M.D., Ahsan Khan, M.D., Patrick McGrath, M.D., Diane Warden, Ph.D., A. John Rush, M.D. and Madhukar Trivedi, M.D. Psychiatric Services […]